Showing results (101-110 of 222) with videos related to
Sort By:
Pageof 23
British Journal of Cancer|May 19, 2000
Polymorphisms in GSTM1, GSTT1 and CYP1A1 and risk of pancreatic adenocarcinomaG Liu, P Ghadirian, D Vesprini, et al.British Journal of Cancer|December 18, 2008
Breast cancer risks in women with a family history of breast or ovarian cancer who have tested negative for a BRCA1 or BRCA2 mutationK A Metcalfe, A Finch, A Poll, et al.Nature Genetics|August 1, 1996
Evidence for a familial Wilms' tumour gene (FWT1) on chromosome 17q12-q21N Rahman, L Arbour, P Tonin, et al.American Journal of Human Genetics|March 20, 2001
HPC2 variants and screen-detected prostate cancerD Vesprini, R K Nam, J Trachtenberg, et al.Archives of Internal Medicine|September 13, 1993
DNA screening for breast/ovarian cancer susceptibility based on linked markers. A family studyH T Lynch, P Watson, T A Conway, et al.Familial Cancer|October 24, 2003
Double primary cancers of the breast and thyroid in women: molecular analysis and genetic implicationsT Pal, N Hamel, D Vesprini, et al.American Journal of Obstetrics and Gynecology|September 10, 1998
Risk factors for familial and sporadic ovarian cancer among French Canadians: a case-control studyB Godard, W D Foulkes, D Provencher, et al.Clinical Genetics|March 23, 2013
Rates of risk-reducing surgery in Israeli BRCA1 and BRCA2 mutation carriersY Laitman, Y Vaisman, D Feldman, et al.Clinical Genetics|July 26, 2014
Strategies for recruitment of relatives of BRCA mutation carriers to a genetic testing program in the BahamasM Trottier, J Lunn, R Butler, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2000
Serum human glandular kallikrein-2 protease levels predict the presence of prostate cancer among men with elevated prostate-specific antigenR K Nam, E P Diamandis, A Toi, et al.Pageof 23